Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A personalized approach ensures youre eating safely while still reaching your goals
CJC-1295 (Modified GRF 1-29) is the GHRH receptor agonist component
The 12 mg row is included for completeness because the Phase 2 trial escalated through 1 mg, 2 mg, 4 mg, 8 mg and 12 mg arms, with the 12 mg cohort reaching approximately 24.2% mean weight loss at 48 weeks at the cost of a heavier nausea and constipation burden [2][5]
doi: 10.1517/14656566.2013.838559 66 ChristensenMMiossecPLarsenBDWernerUKnopFK
571 Other interventions include gastric electrical stimulation 572 and optimizing glycemic control
US$ 28.82
US$ 24.18
US$ 29.00
US$ 20.00
US$ 25.20
US$ 24.40
US$ 29.25
